Journal articleAnn Med Surg (Lond)2026

Daraxonrasib in metastatic pancreatic cancer (RASolute 302): survival breakthrough or real-world access barrier?

DOI 10.1097/ms9.0000000000005214 ↗ PubMed Central open-access subset, retrieved 5 November 2026

Journal: Ann Med Surg (Lond)
Published: 3 June 2026
Citations: 0
Type: Article
License: cc by
Full text: Open access, reuse-licensed (cc by)

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.

Try